All News #Library
Biotech
Tilt Biotherapeutics Closes USD 25M Series B Financing
13 May 2025 //
GLOBENEWSWIRE
TILT Bio Updates International Cancer Immunotherapy Trial
05 Dec 2024 //
GLOBENEWSWIRE
TILT Presents TILT-123 IV Delivery Data At ESMO 2024
09 Sep 2024 //
GLOBENEWSWIRE
TILT Bio: TILT-123 Ovarian Cancer Data Presented At ASCO 2024
28 May 2024 //
GLOBENEWSWIRE
First patient dosed in TILT-123 Phase I trial
15 May 2023 //
CLINICAL TRIALS ARENA

Market Place
Sourcing Support